The overexpression of Prdx2 rendered leukemia and stomach cancer cells resistant to various chemotherapeutic agents [9,10], and the downregulation of Prdx2 sensitized head and neck cancer cells to radiation and gastric carcinoma cells to cisplatin [11,12]. This evidence concerns the gene PRDX2 and leukemia.